UP-REGULATION OF CLASS-I MAJOR HISTOCOMPATIBILITY COMPLEX ANTIGENS BY INTERFERON-GAMMA IS NECESSARY FOR T-CELL-MEDIATED ELIMINATION OF RECOMBINANT ADENOVIRUS-INFECTED HEPATOCYTES IN-VIVO

被引:231
作者
YANG, YP
XIANG, ZQ
ERTL, HCJ
WILSON, JM
机构
[1] UNIV PENN,INST HUMAN GENE THERAPY,PHILADELPHIA,PA 19104
[2] UNIV PENN,DEPT MED,PHILADELPHIA,PA 19104
[3] UNIV PENN,DEPT MOLEC & CELLULAR ENGN,PHILADELPHIA,PA 19104
[4] WISTAR INST ANAT & BIOL,PHILADELPHIA,PA 19104
关键词
D O I
10.1073/pnas.92.16.7257
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Recombinant adenoviruses are attractive vehicles for liver directed gene therapy because of the high efficiency with which they transfer genes to hepatocytes in vivo. First generation recombinant adenoviruses deleted of E1 sequences also express recombinant and early and late viral genes, which lead to development of destructive cellular immune responses, Previous studies indicated that class I major histocompatibility complex (MHC)-restricted cytotoxic T lymphocytes (CTLs) play a major role in eliminating virus-infected cells. The present studies utilize mouse models to evaluate the role of T-helper cells in the primary response to adenovirus-mediated gene transfer to the liver. In vivo ablation of CD4(+) cells or interferon gamma (IFN-gamma) was sufficient to prevent the elimination of adenovirus-transduced hepatocytes, despite the induction of a measurable CTL response, Mobilization of an effective T-H1 response as measured by in vitro proliferation assays was associated with substantial upregulation of MHC class I expression, an effect that was prevented in IFN-gamma-deficient animals. These results suggest that elimination of virus-infected hepatocytes in a primary exposure to recombinant adenovirus requires both induction of antigen-specific CTLs as well as sensitization of the target cell by T-H1-mediated activation of MHC class I expression.
引用
收藏
页码:7257 / 7261
页数:5
相关论文
共 32 条
[1]   MECHANISMS OF CLASS-I RESTRICTED IMMUNOPATHOLOGY - A TRANSGENIC MOUSE MODEL OF FULMINANT-HEPATITIS [J].
ANDO, K ;
MORIYAMA, T ;
GUIDOTTI, LG ;
WIRTH, S ;
SCHREIBER, RD ;
SCHLICHT, HJ ;
HUANG, SN ;
CHISARI, FV .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (05) :1541-1554
[2]   ENHANCED ESTABLISHMENT OF A VIRUS CARRIER STATE IN ADULT CD4+ T-CELL-DEFICIENT MICE [J].
BATTEGAY, M ;
MOSKOPHIDIS, D ;
RAHEMTULLA, A ;
HENGARTNER, H ;
MAK, TW ;
ZINKERNAGEL, RM .
JOURNAL OF VIROLOGY, 1994, 68 (07) :4700-4704
[3]   MULTIPLE DEFECTS OF IMMUNE CELL-FUNCTION IN MICE WITH DISRUPTED INTERFERON-GAMMA GENES [J].
DALTON, DK ;
PITTSMEEK, S ;
KESHAV, S ;
FIGARI, IS ;
BRADLEY, A ;
STEWART, TA .
SCIENCE, 1993, 259 (5102) :1739-1742
[4]   CLEARANCE OF INFLUENZA-VIRUS RESPIRATORY-INFECTION IN MICE LACKING CLASS-I MAJOR HISTOCOMPATIBILITY COMPLEX-RESTRICTED CD8+ T-CELLS [J].
EICHELBERGER, M ;
ALLAN, W ;
ZIJLSTRA, M ;
JAENISCH, R ;
DOHERTY, PC .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 174 (04) :875-880
[5]   PROLONGED TRANSGENE EXPRESSION IN COTTON RAT LUNG WITH RECOMBINANT ADENOVIRUSES DEFECTIVE IN E2A [J].
ENGELHARDT, JF ;
LITZKY, L ;
WILSON, JM .
HUMAN GENE THERAPY, 1994, 5 (10) :1217-1229
[6]   ADENOVIRUS-MEDIATED TRANSFER OF THE CFTR GENE TO LUNG OF NONHUMAN-PRIMATES - BIOLOGICAL EFFICACY STUDY [J].
ENGELHARDT, JF ;
SIMON, RH ;
YANG, YP ;
ZEPEDA, M ;
WEBERPENDLETON, S ;
DORANZ, B ;
GROSSMAN, M ;
WILSON, JM .
HUMAN GENE THERAPY, 1993, 4 (06) :759-769
[7]   DIRECT GENE-TRANSFER OF HUMAN CFTR INTO HUMAN BRONCHIAL EPITHELIA OF XENOGRAFTS WITH E1-DELETED ADENOVIRUSES [J].
ENGELHARDT, JF ;
YANG, YP ;
STRATFORDPERRICAUDET, LD ;
ALLEN, ED ;
KOZARSKY, K ;
PERRICAUDET, M ;
YANKASKAS, JR ;
WILSON, JM .
NATURE GENETICS, 1993, 4 (01) :27-34
[8]   INTERFERON-DEPENDENT INDUCTION OF MESSENGER-RNA FOR THE MAJOR HISTOCOMPATIBILITY ANTIGENS IN HUMAN-FIBROBLASTS AND LYMPHOBLASTOID-CELLS [J].
FELLOUS, M ;
NIR, U ;
WALLACH, D ;
MERLIN, G ;
RUBINSTEIN, M ;
REVEL, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1982, 79 (10) :3082-3086
[9]   LYMPHOCYTE-MEDIATED CYTOTOXICITY - 2 PATHWAYS AND MULTIPLE EFFECTOR MOLECULES [J].
HENKART, PA .
IMMUNITY, 1994, 1 (05) :343-346
[10]  
HOU S, 1992, J IMMUNOL, V149, P1319